Enanta Pharmaceuticals, Inc. (ENTA) SEC filings

ENTA SEC filings moved a median of +0.46% by the close. ENTA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ENTA overview →

53 measured ENTA SEC filing events.

Where these ENTA SEC filings landedvs 51 measured ENTA SEC filing reactions
ENTA SEC filingMiddle 50% · -1.49% to +4.64%Zero: 0.00%Median: +0.46%Median +0.46%-6.00%0+6.00%
Middle 50% of ENTA SEC filing reactions-1.49% to +4.64%
Median reaction (to close)+0.46%
Measured reactions51
Point-in-time · zero look-ahead

Half of the 51 ENTA SEC filing events with a measured close landed between -1.49% and +4.64%; 65% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q-0.56%+0.15%
Form 8-K ENANTA PHARMACEUTICALS For: Jul 02SEC filing · Form 8-K-0.67%-2.62%
Form 8-K ENANTA PHARMACEUTICALS For: Jun 23SEC filing · Form 8-K+1.14%-2.56%
Form 8-K ENANTA PHARMACEUTICALS For: Jun 18SEC filing · Form 8-K-0.62%-1.63%
Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q+0.94%-2.37%
Form S-8 ENANTA PHARMACEUTICALSSEC filing · Form S-8+0.94%-2.37%
Form 8-K ENANTA PHARMACEUTICALS For: May 11SEC filing · Form 8-K-3.13%-3.26%
Form 8-K ENANTA PHARMACEUTICALS For: Mar 20SEC filing · Form 8-K+1.38%+1.63%
Form 8-K ENANTA PHARMACEUTICALS For: Mar 11SEC filing · Form 8-K+0.00%—
Form EFFECT ENANTA PHARMACEUTICALSSEC filing · Form EFFECT+0.81%-0.59%
Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31SEC filing · Form 10-Q+0.14%-1.35%
Form S-3 ENANTA PHARMACEUTICALSSEC filing · Form S-3+0.14%-1.35%
Form 8-K ENANTA PHARMACEUTICALS For: Feb 09SEC filing · Form 8-K-3.45%-6.55%
Form ARS ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form ARS-2.63%+0.46%
Form DEF 14A ENANTA PHARMACEUTICALS For: Mar 11SEC filing · Form DEF-2.63%+0.46%
Form DEFA14A ENANTA PHARMACEUTICALSSEC filing · Form DEFA14A-2.63%+0.46%
Form 10-K ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-K+0.00%-1.30%
Form 8-K ENANTA PHARMACEUTICALS For: Nov 17SEC filing · Form 8-K+0.41%+1.15%
Form 8-K ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form 8-K+1.69%-3.00%
Form 8-K ENANTA PHARMACEUTICALS For: Sep 29SEC filing · Form 8-K+6.85%+112.03%
Form 8-K ENANTA PHARMACEUTICALS For: Aug 26SEC filing · Form 8-K-0.12%+1.76%
Form 8-K ENANTA PHARMACEUTICALS For: Aug 20SEC filing · Form 8-K+0.36%+6.65%
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q+0.73%+3.34%
Form 8-K ENANTA PHARMACEUTICALS For: Aug 11SEC filing · Form 8-K+8.04%—
Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q+1.35%+3.67%
Form S-8 ENANTA PHARMACEUTICALSSEC filing · Form S-8+1.35%+3.67%
Form 8-K ENANTA PHARMACEUTICALS For: May 12SEC filing · Form 8-K-0.18%-5.08%
Form 8-K ENANTA PHARMACEUTICALS For: Mar 13SEC filing · Form 8-K-0.17%+5.53%
Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31SEC filing · Form 10-Q+8.28%+21.75%
Form 8-K ENANTA PHARMACEUTICALS For: Feb 10SEC filing · Form 8-K+2.67%+6.48%
Form ARS ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form ARS-1.72%-2.10%
Form DEF 14A ENANTA PHARMACEUTICALS For: Mar 13SEC filing · Form DEF-1.72%-2.10%
Form DEFA14A ENANTA PHARMACEUTICALSSEC filing · Form DEFA14A-1.72%-2.10%
Form 8-K ENANTA PHARMACEUTICALS For: Dec 09SEC filing · Form 8-K-2.34%+10.10%
Form 10-K ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-K+1.41%+3.76%
Form 8-K ENANTA PHARMACEUTICALS For: Nov 25SEC filing · Form 8-K-1.48%-2.73%
Form 10-Q ENANTA PHARMACEUTICALS For: Jun 30SEC filing · Form 10-Q-3.25%+6.89%
Form 8-K ENANTA PHARMACEUTICALS For: Aug 05SEC filing · Form 8-K+0.76%+4.00%
Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31SEC filing · Form 10-Q-0.54%+0.15%
Form S-8 ENANTA PHARMACEUTICALSSEC filing · Form S-8-0.54%+0.15%
Form 8-K ENANTA PHARMACEUTICALS For: May 06SEC filing · Form 8-K+9.91%+12.93%
Form 8-K ENANTA PHARMACEUTICALS For: Mar 06SEC filing · Form 8-K+0.00%-0.07%
Form EFFECT ENANTA PHARMACEUTICALSSEC filing · Form EFFECT+0.00%+0.16%
Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31SEC filing · Form 10-Q+0.00%+0.16%
Form 8-K ENANTA PHARMACEUTICALS For: Feb 07SEC filing · Form 8-K+2.34%+11.25%
Form ARS ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form ARS-1.39%+2.37%
Form DEF 14A ENANTA PHARMACEUTICALS For: Mar 06SEC filing · Form DEF-1.39%+2.37%
Form DEFA14A ENANTA PHARMACEUTICALSSEC filing · Form DEFA14A-1.39%+2.37%
Form 8-K ENANTA PHARMACEUTICALS For: Dec 19SEC filing · Form 8-K+1.96%+1.47%
Form 10-K ENANTA PHARMACEUTICALS For: Sep 30SEC filing · Form 10-K+0.00%+11.06%
Form POSASR ENANTA PHARMACEUTICALSSEC filing · Form POSASR+0.00%+11.06%
Form S-3 ENANTA PHARMACEUTICALSSEC filing · Form S-3+0.00%+11.06%
Form 8-K ENANTA PHARMACEUTICALS For: Nov 20SEC filing · Form 8-K+8.98%+5.28%
That’s how ENTA usually reacts to SEC filings — get an email when it moves on news →
Keep exploring

More ENTA: earnings → · analyst actions → · ENTA overview →

Other Healthcare names and their SEC filings

TickerEventsMedian 30-min% positive
Haemonetics Corporation (HAE)261-0.07%44%
Avanos Medical, Inc. (AVNS)2590.00%45%
FORTY SEVEN (FTSV)257+0.01%51%
SELLAS Life Sciences Group, Inc. (SLS)257-0.63%42%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.